Cardio-metabolic disease risk assessment in urban school going adolescent age group (10-19 years) using lipid biomarkers: A Cross-Sectional study
Reg No: 253
DOI:
https://doi.org/10.56450/JEFI.2025.v3i2Suppl.023Abstract
Introduction: Dyslipidaemia is a major risk factor for Cardio-metabolic disease and its complications which is showing an increasing trends in adults worldwide. Lipid imbalance detection during adolescent period can forecast the development of cardio-metabolic disease in adulthood.
The Primary Objective of the study was to assess the lipid profile parameters in the school going urban adolescents of the age group of 10-19 years. Secondary Objectives: To find out the prevalence of metabolic syndrome among the study population using NCEP-III criteria. Methods: It was an observational analytical cross-sectional study conducted for a period of two years in the school going urban adolescents of the age group of 10-19 years. Sample size was 679.
Results: Out of 679 study population female were 554 (81.6% ) and 125(18.4% ) males. The mean age among male & female respondents were 13.8±0.9 & 14.7±1.8 years respectively. Majority of the respondents from both the gender belongs to the age group of 14-16 years [Male- 81( 64.8%), Female-366(66.1%)]. The overall results revealed that prevalence of dyslipidaemia & Metabolic syndrome was found to be 496 (73%) & 47(6.9%). Majority of the participants had low HDL Value { females- 400(72.2%) , Males- 96(76.8%). High triglyceride level was seen in {Female- 119(21.5%) ,Male- 18(14.4%)}. Borderline & high LDL value was observed in seven(1.3%) females only. Borderline cholesterol levels were seen in [Female- 21 (3.8%) and male- 2(1.6%)]. Seven(1.6%) female participants had very high cholesterol level. Total of 72(10.6%) adolescents had blood pressure ≥130/85mm of HG.
Conclusion: Early risk assessment should begin in adolescence in order to design and implement lifestyle or pharmacological interventions that might be effective in preventing the mortality & morbidity caused by Cardiometabolic disease in adulthood.
Keywords: Atherosclerosis, CVD, Dyslipidaemia , lipid markers, NCEP-III guidelines.
Downloads
References
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sushree Priyadarsini Satapathy, Rabinarayan Dash (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
